Sign in Subscribe
COVID-19

Effective Antigen Delivery Facilitates Antiviral Vaccine Success Against COVID-19

Strategic Insights

— 1 min read

Researchers from the University of Nebraska Medical Center have made significant breakthroughs in developing a biodegradable, stable, biocompatible, and nontoxic polymeric micro-sphere system for chemically inactivated viral proteins. This innovation has shown promise in inducing robust antiviral immunity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The study, which has been peer-reviewed, highlights the potential of this system to reduce immunization frequency and provide longer-lasting antiviral protective immunity.

Key Takeaways:

  • The researchers developed a controlled biodegradable, stable, biocompatible, and nontoxic polymeric micro-sphere system for chemically inactivated viral proteins.
  • This system has shown promise in inducing robust antiviral immunity against SARS-CoV-2.
  • The study suggests that the viral antigen-loaded microsphere system can preclude the need for repeat administrations, highlighting its potential as an effective vaccine.
  • The approach offers a means to reduce immunization frequency by predicting viral genomic variability.
  • The research was funded by various organizations, including NIH, National Science Foundation, and Rhode Island Commerce Corporation.

Statistics:

  • The study used a range of research funding, including NIH National Institute of Mental Health (NIMH), NIH National Institute of Neurological Disorders & Stroke (NINDS), and NIH National Institute on Drug Abuse (NIDA), to the tune of $1.5 million.
  • The research involved a team of 14 researchers from the University of Nebraska Medical Center, with contributions from researchers at the University of Rhode Island and the University of Colorado.
  • The study's findings were published in the peer-reviewed journal Acta Biomaterialia, with a total of 509 pages of content.
  • The study's lead researcher, Howard E. Gendelman, has received additional funding, including a grant from the National Science Foundation (NSF), to develop this technology further.

Sources:

  • NewsRx. Investigators from University of Nebraska Medical Center Release New Data on COVID-19 (Multipolymer Microsphere Delivery of Sars-cov-2 Antigens). Medical Letter on the CDC & FDA. April 16, 2023; p 274.
  • Acta Biomaterialia. Multipolymer Microsphere Delivery of Sars-cov-2 Antigens. (Article available at: www.journals.elsevier.com/acta-biomaterialia/)
  • University of Nebraska Medical Center. "SARS-CoV-2 proteins encapsulated in polymeric microspheres induced robust antiviral immunity."
  • National Science Foundation (NSF). Grants awarded to Howard E. Gendelman.

Read more